These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

547 related articles for article (PubMed ID: 27989385)

  • 21. Cannabis, cannabidiol, and epilepsy--from receptors to clinical response.
    Szaflarski JP; Bebin EM
    Epilepsy Behav; 2014 Dec; 41():277-82. PubMed ID: 25282526
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence for cannabis and cannabinoids for epilepsy: a systematic review of controlled and observational evidence.
    Stockings E; Zagic D; Campbell G; Weier M; Hall WD; Nielsen S; Herkes GK; Farrell M; Degenhardt L
    J Neurol Neurosurg Psychiatry; 2018 Jul; 89(7):741-753. PubMed ID: 29511052
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An Australian nationwide survey on medicinal cannabis use for epilepsy: History of antiepileptic drug treatment predicts medicinal cannabis use.
    Suraev AS; Todd L; Bowen MT; Allsop DJ; McGregor IS; Ireland C; Lintzeris N
    Epilepsy Behav; 2017 May; 70(Pt B):334-340. PubMed ID: 28238865
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The case for medical marijuana in epilepsy.
    Maa E; Figi P
    Epilepsia; 2014 Jun; 55(6):783-6. PubMed ID: 24854149
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Interplay between the Endocannabinoid System, Epilepsy and Cannabinoids.
    Cheung KAK; Peiris H; Wallace G; Holland OJ; Mitchell MD
    Int J Mol Sci; 2019 Dec; 20(23):. PubMed ID: 31810321
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exploiting cannabinoid and vanilloid mechanisms for epilepsy treatment.
    Asth L; Iglesias LP; De Oliveira AC; Moraes MFD; Moreira FA
    Epilepsy Behav; 2021 Aug; 121(Pt B):106832. PubMed ID: 31839498
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic Use of Δ9-THC and Cannabidiol: Evaluation of a New Extraction Procedure for the Preparation of Cannabis-based Olive Oil.
    Morini L; Porro G; Liso M; Groppi A
    Curr Pharm Biotechnol; 2017; 18(10):828-833. PubMed ID: 29189144
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extensive phytocannabinoid profiles of seized cannabis and cannabis-based medicines - Identification of potential distinguishing markers.
    Scheunemann A; Elsner K; Germerott T; Hess C; Zörntlein S; Röhrich J
    Forensic Sci Int; 2021 May; 322():110773. PubMed ID: 33839545
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cannabis cultivation: Methodological issues for obtaining medical-grade product.
    Chandra S; Lata H; ElSohly MA; Walker LA; Potter D
    Epilepsy Behav; 2017 May; 70(Pt B):302-312. PubMed ID: 28202406
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Medical use of cannabis products: Lessons to be learned from Israel and Canada.
    Ablin J; Ste-Marie PA; Schäfer M; Häuser W; Fitzcharles MA
    Schmerz; 2016 Feb; 30(1):3-13. PubMed ID: 26767992
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cannabinoids in epilepsy: clinical efficacy and pharmacological considerations.
    Espinosa-Jovel C
    Neurologia (Engl Ed); 2023; 38(1):47-53. PubMed ID: 34824031
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phytocannabinoids and epilepsy.
    dos Santos RG; Hallak JE; Leite JP; Zuardi AW; Crippa JA
    J Clin Pharm Ther; 2015 Apr; 40(2):135-43. PubMed ID: 25475762
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Path to the First FDA-Approved Cannabis-Derived Treatment and What Comes Next.
    Rubin R
    JAMA; 2018 Sep; 320(12):1227-1229. PubMed ID: 30193358
    [No Abstract]   [Full Text] [Related]  

  • 34. Cannabis y los sistemas exocannabinoide y endocannabinoide. Su uso y controversias.
    Millán-Guerrero RO; Isais-Millán S
    Gac Med Mex; 2019; 155(5):508-512. PubMed ID: 31695229
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A perspective on cannabinoids for treating epilepsy: Do they really change the landscape?
    Cross JH; Cock H
    Neuropharmacology; 2020 Jun; 170():107861. PubMed ID: 31770546
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Pharmacological Basis of Cannabis Therapy for Epilepsy.
    Reddy DS; Golub VM
    J Pharmacol Exp Ther; 2016 Apr; 357(1):45-55. PubMed ID: 26787773
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [There is evidence for the use of cannabinoids for symptomatic treatment of multiple sclerosis].
    Basinski H; Jensen HB; Stenager E
    Ugeskr Laeger; 2014 Mar; 176(12A):. PubMed ID: 25350886
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Practical considerations in medical cannabis administration and dosing.
    MacCallum CA; Russo EB
    Eur J Intern Med; 2018 Mar; 49():12-19. PubMed ID: 29307505
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical uses of cannabis and cannabinoids in the United States.
    Levinsohn EA; Hill KP
    J Neurol Sci; 2020 Apr; 411():116717. PubMed ID: 32044684
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Marijuana: a time-honored but untested treatment for epilepsy.
    McLachlan RS
    Can J Neurol Sci; 2015 Mar; 42(2):88-91. PubMed ID: 25715711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.